Medigene

Medigene EBIT per Share

Delisted·Jul 2, 2026

The EBIT per Share of Medigene (MDG1.DE) as of Oct 19, 2026 is -0.65 EUR. In the previous year, EBIT per Share was -0.36 EUR — a change of 83.53% (lower).

EBIT per Share

-0.65EUR

YoY

83.53%

Last updated:

EBIT per Share of Medigene is 2023 -0.65 EUR. EBIT per Share of Medigene was 2022 -0.36 EUR. It decreases by 83.53% lower compared to the previous year.

The Medigene EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
-0.65 EUR
Jan 1, 2024 (e)
-1.02 EUR
Jan 1, 2025 (e)
0.24 EUR
Jan 1, 2026 (e)
-0.91 EUR
Jan 1, 2027 (e)
-0.86 EUR
Jan 1, 2028 (e)
-0.66 EUR
Jan 1, 2029 (e)
-0.64 EUR
Jan 1, 2030 (e)
0.00 EUR
The Medigene EBIT per Share history
YEAREBIT per ShareYoY
est0.00EUR-100.00%
est-0.64EUR-2.30%
est-0.66EUR-22.99%
est-0.86EUR-5.41%
est-0.91EUR-473.34%
est0.24EUR-123.74%
est-1.02EUR+56.36%
-0.65EUR+83.53%
-0.36EUR-7.78%
-0.39EUR-57.21%
-0.90EUR+9.90%
-0.82EUR+13.11%
-0.73EUR+33.13%
-0.55EUR+47.10%
-0.37EUR-12.81%
-0.42EUR+80.13%
-0.24EUR-87.40%
-1.87EUR-46.77%
-3.52EUR+4.54%
-3.37EUR-44.24%
-6.04EUR+31.54%
-4.59EUR-161.55%
7.46EUR-192.84%
-8.03EUR+244.16%
-2.33EUR-53.00%
-4.97EUR-39.53%
-8.21EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medigene Stock analysis

What does Medigene do? Medigene AG, based in Planegg, Germany, is a biotechnology company specializing in developing innovative cancer treatment platforms. The company focuses on personalized T cell-based immunotherapies, including TCR-modified T cells for adoptive therapy, dendritic cell vaccines for low tumor burdens, and T-cell-specific monoclonal antibodies. It operates offices in Martinsried, Germany, and in Washington DC and San Diego, USA, with 136 employees. Medigene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medigene stock

EBIT per Share of Medigene is -0.65 EUR in 2023.

EBIT per Share of Medigene changed from -0.36 EUR to -0.65 EUR, representing a 83.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Medigene since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Medigene

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Medigene